Medical Oncology

Indiana University   

Questions discussed in this category



What are the risks of infection with COVID-19 if using immunotherapy?  

What would be the next line of treatment, PRRT, capecitabine and temozolomide or other?

In a patient with lung cancer with both NSCLC and SCLC components, would you offer carbo/pem/pembro or carbo/etoposide/atezolizumab? Or any other alte...

There is no evidence of disease outside the lung on PET, and the patient is completely asymptomatic with negative EGFR, ALK, ROS1, and BRAF and a PD-L...


Papers discussed in this category


J. Clin. Oncol., 2020 Feb 20

N. Engl. J. Med., 2019 May 31

The New England journal of medicine, 2018-12-06

J Thorac Oncol, 2019 Jan 18

Int J Cancer, 2018 Apr 15

JAMA Oncol, 2019 Oct 31

Eur J Surg Oncol, 2014 Oct 07

Annals of surgical oncology, 2018-08

Lancet, 2019 Oct 04

The New England journal of medicine, 2018-05-31